Argues Continued Deterioration of Stock Price and Key Financial Metrics Demonstrate Urgent Need for Meaningful Board Change Criticizes Failure of Board to Meaningfully Engage with EHS's Highly Qualified Director Nominees NEW YORK, March 3, 2026 /PRNewswire/ -- EHS Investments ("EHS"), a significant shareholder of TrueBlue Inc. (NYSE: TBI) ("TrueBlue" or the "Company"), today issued the following statement: We have argued publicly and privately that the minor refreshment to its Board of Directors ("Board") announced by TrueBlue earlier this year does not adequately address what is required to address the Company's serious operational and financial challenges, and that further change at the Board level is necessary to prevent continued and significant destruction of shareholder value. TrueBlue's fourth quarter results and 2026 guidance substantiate the immediate need for such change.

TrueBlue, Inc. posted 5% organic growth and 8% total revenue growth to $418M. TBI energy revenue surged 60%, doubling two straight quarters, now 15% of the mix. Q1 guide: 3%–9% revenue growth.

TrueBlue, Inc. (TBI) Q4 2025 Earnings Call Transcript

TrueBlue (TBI) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.02 per share a year ago.

New digital health platform being launched in partnership with UCSD allows remote physician-monitored neurotherapy subscription models to expand reach, lower cost, and break down treatment stigma for brain-health disorders New digital health platform being launched in partnership with UCSD allows remote physician-monitored neurotherapy subscription models to expand reach, lower cost, and break down treatment stigma for brain-health disorders

TACOMA, Wash.--(BUSINESS WIRE)--TrueBlue, Inc. (NYSE: TBI) (“TrueBlue” or the “Company”) today issued the following statement in response to the comments made by, and nominations from, EHS Management, LLC (“EHS”): TrueBlue is executing a disciplined and decisive plan that is leading to improved financial results, and the Company is well on its way to returning to sustainable, profitable growth. Under our strategic plan, TrueBlue has strengthened performance in attractive end markets, particular.

Calls Out Ongoing Operational and Financial Deterioration Expresses Concern with Widening Gap Between Board's Self-Assessment and TrueBlue's Reality Commits to Putting Forth Highly Qualified Nominees to Drive Shareholder Value NEW YORK , Dec. 2, 2025 /PRNewswire/ -- EHS Investments ("EHS"), a significant shareholder of TrueBlue, Inc. (NYSE: TBI) (the "Company"), today announced its intention to nominate a slate of highly qualified director candidates for election to the Company's Board of Directors (the "Board") at the upcoming 2026 Annual Meeting of Shareholders. "TrueBlue remains on the wrong path as operational performance continues to deteriorate and the share price approaches all-time lows.

TrueBlue, Inc. shows early signs of stabilization, with Q3 revenue up 13% and notable growth in skilled labor and energy sectors. TBI stock remains undervalued versus peers on sales and book value, but persistent weak profitability and negative margins justify a cautious outlook. Operational improvements, cost controls, and digital initiatives are helping, yet macro headwinds and uneven recovery across divisions persist.

TrueBlue, Inc. ( TBI ) Q3 2025 Earnings Call November 3, 2025 5:00 PM EST Company Participants Taryn Owen - CEO, President & Director Carl Schweihs - EVP & CFO Conference Call Participants Marc Riddick - Sidoti & Company, LLC Jeffrey Silber - BMO Capital Markets Equity Research Kartik Mehta - Northcoast Research Partners, LLC Presentation Operator Greetings, and welcome to the TrueBlue Third Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.

TrueBlue (TBI) Q2 Loss Improves 80%